J Gynecol Oncol.  2018 Jul;29(4):e50. 10.3802/jgo.2018.29.e50.

Are patients and physicians willing to accept less-radical procedures for cervical cancer?

Affiliations
  • 1Department of Gynecologic Oncology, MuÄŸla Sıtkı Koçman University, Education and Research Hospital, MuÄŸla, Turkey. drkemalgungorduk@gmail.com
  • 2Department of Obstetrics and Gynecology, Gynecologic Oncology Center, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • 3Department of Gynecologic Oncology, Etlik Zübeyde Hanım Education and Research Hospital, Ankara, Turkey.

Abstract


OBJECTIVE
To evaluate the opinions of women who underwent surgery for cervical cancer (CC) and physicians who treat CC about the acceptability of increased oncological risk after less-radical surgery.
METHODS
One hundred eighty-two women who underwent surgery for CC and 101 physicians participated in a structured survey in 3 tertiary cancer centers in Czech Republic and Turkey. Patients and physicians were asked whether they would accept any additional oncological risks, which would be attributable to the omission of parametrectomy (radical hysterectomy/trachelectomy vs. simple hysterectomy/trachelectomy) or pelvic lymph node dissection (systematic resection vs. sentinel lymph node sampling).
RESULTS
Although 52.2% of patients reported morbidity related to their previous treatment, the majority of patients would not accept less-radical surgical treatment if it was associated with any increased risk of recurrence (50%-55%, no risk; 17%-24%, risk < 0.1%). Physicians tended to accept a significantly higher risk than patients in the Czech Republic, but not in Turkey. Patients with higher education levels, more advanced-stage of disease, or adverse events related to previous cancer treatment, and patients who received adjuvant therapy were significantly more likely to accept an increased oncological risk.
CONCLUSION
Patients, even if they suffered from morbidity related to previous CC treatment, do not want to choose between oncological safety and a better quality of life. Physicians tend to accept the higher oncological risk associated with less-radical surgical procedures, but attitudes differ regionally. Professionals should be aware of this tendency when counselling the patients before less-radical surgery.

Keyword

Uterine Cervical Neoplasms; Surgery; Morbidity; Quality of Life

MeSH Terms

Czech Republic
Education
Female
Humans
Lymph Node Excision
Lymph Nodes
Quality of Life
Recurrence
Turkey
Uterine Cervical Neoplasms*

Figure

  • Fig. 1. Visual comparison of the patients' and physicians' risk acceptance. The mean values of the subjective oncological risk acceptance are visualized. Hyst.=simple hysterectomy instead of RH; Lymph.=removal of SLNs only instead of pelvic lymphadenectomy; Trach.=simple trachelectomy instead of radical trachelectomy; Total=these three questions together. RH, radical hysterectomy; SLN, sentinel lymph node.


Reference

References

1. Barakat RR, Berchuck A, Markman M, Randall ME. Principles and practice of gynecologic oncology. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins;2013.
2. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997; 350:535–40.
Article
3. Cibula D, Sláma J, Svárovský J, Fischerova D, Freitag P, Zikán M, et al. Abdominal radical trachelectomy in fertility-sparing treatment of early-stage cervical cancer. Int J Gynecol Cancer. 2009; 19:1407–11.
Article
4. Rema P, Ahmed I. Conservative surgery for early cervical cancer. Indian J Surg Oncol. 2016; 7:336–40.
Article
5. Ye S, Yang J, Cao D, Zhu L, Lang J, Chuang LT, et al. Quality of life and sexual function of patients following radical hysterectomy and vaginal extension. J Sex Med. 2014; 11:1334–42.
Article
6. Xue Z, Zhu X, Teng Y. Comparison of nerve-sparing radical hysterectomy and radical hysterectomy: a systematic review and meta-analysis. Cell Physiol Biochem. 2016; 38:1841–50.
Article
7. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005; 23:7428–36.
Article
8. Baiocchi G, de Brot L, Faloppa CC, Mantoan H, Duque MR, Badiglian-Filho L, et al. Is parametrectomy always necessary in early-stage cervical cancer? Gynecol Oncol. 2017; 146:16–9.
Article
9. Landoni F, Maneo A, Zapardiel I, Zanagnolo V, Mangioni C. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study. Eur J Surg Oncol. 2012; 38:203–9.
Article
10. Plante M, Renaud MC, Sebastianelli A, Gregoire J. Simple vaginal trachelectomy: a valuable fertility-preserving option in early-stage cervical cancer. Int J Gynecol Cancer. 2017; 27:1021–7.
11. de Hullu JA, Ansink AC, Tymstra T, van der Zee AG. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynaecol. 2001; 22:199–203.
Article
12. Deeks JJ, Higgins JP. Statistical algorithms in review manager 5. Statistical Methods Group of The Cochrane Collaboration. London: Cochrane;2010.
13. Pagano M, Gauvreau K. Principles of biostatistics. 2nd ed.Pacific Grove, CA: Duxbury;2000.
14. http://www.cancer.gov/clinicaltrials/search/view?cdrid=737208&version=HealthProfessional
15. Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol. 2009; 113:301–5.
Article
16. Farrell R, Gebski V, Hacker NF. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy? Int J Gynecol Cancer. 2014; 24:813–9.
Article
17. van der Voort HP, Grundmeijer HG, Hendrick JM. General practitioner and accurate treatment policies. Huisarts Wet. 1995; 38:351–4.
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr